Skip to content
10-Q

Quarterly Report

Eton Pharmaceuticals, Inc. ETON

0001437749-25-025444

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 26.82M sh
Capex Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2024 $14K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $10.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.22M
Long Term Debt Q2 2025 · Jun 30, 2025 $27.41M
Long Term Debt Q2 2025 · Dec 31, 2024 $29.81M
Short Term Debt Q2 2025 · Jun 30, 2025 $2.77M
Short Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $25.38M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $14.94M
Stockholders Equity Q2 2025 · Jun 30, 2025 $23.96M
Stockholders Equity Q2 2025 · Mar 31, 2025 $24.45M
Stockholders Equity Q2 2025 · Dec 31, 2024 $24.43M
Stockholders Equity Q2 2025 · Jun 30, 2024 $13.46M
Stockholders Equity Q2 2025 · Mar 31, 2024 $15.49M
Stockholders Equity Q2 2025 · Dec 31, 2023 $15.48M
Current Liabilities Q2 2025 · Jun 30, 2025 $38.6M
Current Liabilities Q2 2025 · Dec 31, 2024 $19.95M
Total Liabilities Q2 2025 · Jun 30, 2025 $77.72M
Total Liabilities Q2 2025 · Dec 31, 2024 $51.7M
Current Assets Q2 2025 · Jun 30, 2025 $68.44M
Current Assets Q2 2025 · Dec 31, 2024 $41.02M
Total Assets Q2 2025 · Jun 30, 2025 $101.68M
Total Assets Q2 2025 · Dec 31, 2024 $76.12M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.10
Eps Basic Q2 2025 · Jun 30, 2025 −$0.15
Eps Basic Q2 2025 · Jun 30, 2024 −$0.12
Eps Basic Q2 2025 · Jun 30, 2024 −$0.15
Sga Expense Q2 2025 · Jun 30, 2025 $9.69M
Sga Expense Q2 2025 · Jun 30, 2025 $18.86M
Sga Expense Q2 2025 · Jun 30, 2024 $5.59M
Sga Expense Q2 2025 · Jun 30, 2024 $10.75M
Rd Expense Q2 2025 · Jun 30, 2025 $3.71M
Rd Expense Q2 2025 · Jun 30, 2025 $4.87M
Rd Expense Q2 2025 · Jun 30, 2024 $2.97M
Rd Expense Q2 2025 · Jun 30, 2024 $3.62M
Net Income Q2 2025 · Jun 30, 2025 −$2.59M
Net Income Q2 2025 · Jun 30, 2025 −$4.16M
Net Income Q2 2025 · Jun 30, 2024 −$3.04M
Net Income Q2 2025 · Jun 30, 2024 −$3.85M
Operating Income Q2 2025 · Jun 30, 2025 −$1.48M
Operating Income Q2 2025 · Jun 30, 2025 −$1.95M
Operating Income Q2 2025 · Jun 30, 2024 −$2.94M
Operating Income Q2 2025 · Jun 30, 2024 −$3.74M
Gross Profit Q2 2025 · Jun 30, 2025 $11.92M
Gross Profit Q2 2025 · Jun 30, 2025 $21.79M
Gross Profit Q2 2025 · Jun 30, 2024 $5.63M
Gross Profit Q2 2025 · Jun 30, 2024 $10.63M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $7M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $14.43M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $3.45M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $6.41M
Revenue Q2 2025 · Jun 30, 2025 $18.93M
Revenue Q2 2025 · Jun 30, 2025 $36.21M
Revenue Q2 2025 · Jun 30, 2024 $9.07M
Revenue Q2 2025 · Jun 30, 2024 $17.04M